Why does TRT cause testicular pain? The HPG axis explained.
To understand testicular pain on TRT, you need to understand the hypothalamic-pituitary-gonadal (HPG) axis. Under normal conditions, the hypothalamus releases GnRH (gonadotropin-releasing hormone), which signals the pituitary to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone). LH travels to the testes and stimulates Leydig cells to produce testosterone.
When exogenous testosterone is introduced — via injection, cream, gel, or pellet — the brain detects elevated circulating testosterone and reduces GnRH, LH, and FSH release as negative feedback. With LH suppressed, the Leydig cells in the testes receive no signal to produce intratesticular testosterone. Testicular testosterone production drops, and the testes themselves often shrink in volume (testicular atrophy) as a result.
The aching or dull dragging discomfort that some men experience is thought to result from this process: the reduction in intratesticular pressure as the testes decrease in volume and the adjustment of local supportive structures to the changed size. Some men also notice increased sensitivity of the testicles to touch during this adaptation period.
When testicular pain on TRT is expected versus concerning
Not all testicular pain is mechanistically linked to TRT. A clinician evaluation helps distinguish between the two categories:
- Expected (HPG-suppression related): Bilateral dull ache or sense of heaviness, gradual onset correlating with TRT initiation, associated with reduced testicular volume. Typically manageable and not a reason to stop treatment unless the discomfort is severe.
- Requires prompt evaluation: Unilateral sharp or severe pain, sudden onset, accompanied by nausea, fever, or visible swelling. These features can indicate epididymitis, orchitis, or in rare cases testicular torsion — none of which are caused by TRT but can occur in any man and require urgent evaluation regardless of treatment status.
The general clinical guidance: dull bilateral ache that developed gradually after starting TRT and has no alarming accompanying features is almost certainly HPG suppression-related. Any pain that is sudden, severe, or unilateral with swelling requires same-day evaluation.
A gradual, dull, bilateral ache after starting TRT is almost always benign HPG suppression — sudden, severe, or one-sided pain is not.
Can hCG prevent or relieve testicular pain on TRT?
Human chorionic gonadotropin (hCG) is a hormone that structurally resembles LH and binds to LH receptors on Leydig cells. When co-administered with testosterone, hCG effectively replaces the LH signal that exogenous testosterone suppresses, maintaining intratesticular testosterone production and preventing or reversing testicular atrophy.
Studies confirm that low-dose hCG added to testosterone therapy maintains intratesticular testosterone at significantly higher levels than testosterone alone, preserves testicular volume, and reduces the discomfort associated with atrophy. Many men who report testicular pain on testosterone monotherapy find relief after hCG is added to their protocol.
hCG requires a separate prescription and is administered via subcutaneous injection, typically two or three times per week. A clinician evaluates whether hCG co-administration is appropriate given an individual’s goals (including fertility preservation), current protocol, and symptom profile.
Other documented TRT side effects and how they are managed
Testicular pain is one of the less commonly discussed TRT side effects. These are the adverse events that appear most consistently in clinical trial data and that standard-of-care monitoring addresses:
Erythrocytosis (elevated red blood cell count)
Testosterone stimulates erythropoiesis via EPO (erythropoietin) upregulation. Elevated hematocrit increases blood viscosity, which carries theoretical cardiovascular risk. Hematocrit is checked at 3 and 6 months initially and at least annually thereafter. Dose adjustment, formulation change, or therapeutic phlebotomy (blood removal) are the management options when hematocrit exceeds roughly 52–54%.
Acne and oily skin
Androgens stimulate sebaceous gland activity. Men who were acne-prone in their teens may notice skin changes with TRT. Most cases are mild and manageable with topical treatments. Switching from intramuscular to daily transdermal delivery (which avoids the testosterone peak of injection) sometimes helps.
Gynecomastia
Testosterone aromatizes (converts) to estradiol. If estradiol rises disproportionately, breast tissue sensitivity or enlargement (gynecomastia) can develop. Aromatase inhibitor use is sometimes considered, though routine aromatase inhibitor co-administration is not standard for all patients. A clinician evaluates estradiol levels and symptom presentation before recommending an adjunctive agent.
Fertility suppression
HPG axis suppression reduces FSH, which drives spermatogenesis. Men on TRT typically have significantly reduced sperm counts and may become transiently infertile during treatment. This is fully disclosed before initiating treatment in men who may want biological children, and fertility-sparing alternatives (such as clomiphene citrate) are discussed.
Sleep apnea
TRT can exacerbate obstructive sleep apnea in predisposed men. Men with a diagnosed or suspected sleep disorder are screened and monitored more closely.
Why labs and clinical oversight matter
Every TRT side effect listed here is manageable when caught early through monitoring. The same adverse events — erythrocytosis in particular — can become genuinely dangerous when TRT is used without any clinical supervision or lab follow-up.
A telehealth TRT protocol that includes baseline labs, therapeutic testosterone prescribed by a licensed clinician, and scheduled follow-up hematocrit and testosterone checks is substantively different from the gray-market testosterone products sold online without prescriptions. The monitoring interval is not bureaucratic overhead — it is what makes the risk-benefit calculation favorable.
Frequently asked questions
Why does TRT cause testicular pain or ache?
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reducing LH and FSH secretion. Without LH signaling, the testes reduce testosterone production and often decrease in size (testicular atrophy). The process of atrophy, and the reduced intratesticular pressure that accompanies it, can cause an aching discomfort — sometimes described as a dull drag or tenderness. This is the most common mechanism behind testicular pain on TRT.
Is testicular pain on TRT dangerous?
The dull ache from HPG suppression and mild testicular atrophy is generally not dangerous, though it warrants noting to your clinician. Pain that is sharp, sudden, severe, or accompanied by swelling, fever, or nausea requires prompt evaluation to rule out unrelated causes such as epididymitis or testicular torsion, which are medical emergencies regardless of TRT status.
Can hCG help with testicular pain on TRT?
Yes. Human chorionic gonadotropin (hCG) binds to LH receptors on Leydig cells in the testes and mimics LH signaling. Adding low-dose hCG to a TRT protocol can maintain intratesticular testosterone production, reduce testicular atrophy, and in many men resolve or prevent the testicular ache associated with HPG suppression. A clinician determines whether hCG co-administration is appropriate for an individual patient.
What other TRT side effects should men know about?
Documented TRT side effects include erythrocytosis (elevated hematocrit), acne and oily skin, fluid retention, breast tissue sensitivity (gynecomastia in some men), suppression of sperm production (reduced fertility during treatment), sleep apnea exacerbation in predisposed individuals, and mood changes. These are monitored through regular lab follow-up.
How is TRT-related erythrocytosis managed?
Erythrocytosis (elevated red blood cell count) is the most commonly monitored TRT side effect. When hematocrit rises above roughly 52–54%, options include reducing the testosterone dose, switching to a different formulation or delivery frequency, therapeutic phlebotomy (blood donation), or adjusting treatment. Regular hematocrit monitoring at 3–6 month intervals is standard of care.
Does testicular atrophy from TRT reverse when treatment stops?
For most men, yes — HPG axis recovery and testicular size normalization occur after stopping TRT, though the timeline varies. Recovery can take months to over a year, depending on the duration of prior TRT use and individual HPG axis responsiveness. Men with pre-existing secondary hypogonadism may have a slower or incomplete recovery. hCG or clomiphene citrate are sometimes used to accelerate HPG axis restart.